IQVIA Holdings/IQV

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About IQVIA Holdings

IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. The Company's Connected Intelligence delivers insights enabling customers to accelerate the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients. The Company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions provides mission critical information, technology solutions and real-world insights and services to life science clients. Research & Development Solutions primarily serves biopharmaceutical clients, provides outsourced clinical research and clinical trial services. Contract Sales & Medical Solutions provides health care provider (including contract sales) and patient engagement services to both biopharmaceutical clients and the broader healthcare market.

Ticker

IQV

Sector

Healthcare

Trading on

NYSE

Industry

Biotechnology & Drugs

CEO

Ari Bousbib

Employees

87,000

Headquarters

Durham, United States

IQVIA Holdings Metrics

BasicAdvanced
$40B
Market cap
29.89
P/E ratio
$7.33
EPS
1.54
Beta
-
Dividend rate
$40B
1.53738
$261.73
$167.42
910K
0.876
202.065
213.367
27.832
3.19%
5.19%
22.11%
6.93%
29.894
2.649
6.292
24.58
3.97%
31.57%
9.67%
72.07%

What the Analysts think about IQVIA Holdings

Analyst Ratings

Majority rating from 22 analysts.
Buy

IQVIA Holdings Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
7.70% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$3.7B
-3.39%
Net income
$288M
-38.59%
Profit margin
7.70%
-36.47%

IQVIA Holdings Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 2.40%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$2.43
$2.49
$2.84
$2.54
-
Expected
$2.37
$2.44
$2.82
$2.48
$2.57
Surprise
2.47%
1.88%
0.68%
2.40%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for IQVIA Holdings stock?

IQVIA Holdings (IQV) has a market cap of $40B as of June 15, 2024.

What is the P/E ratio for IQVIA Holdings stock?

The price to earnings (P/E) ratio for IQVIA Holdings (IQV) stock is 29.89 as of June 15, 2024.

Does IQVIA Holdings stock pay dividends?

No, IQVIA Holdings (IQV) stock does not pay dividends to its shareholders as of June 15, 2024.

When is the next IQVIA Holdings dividend payment date?

IQVIA Holdings (IQV) stock does not pay dividends to its shareholders.

What is the beta indicator for IQVIA Holdings?

IQVIA Holdings (IQV) has a beta rating of 1.54. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the IQVIA Holdings stock price target?

The target price for IQVIA Holdings (IQV) stock is $271.24, which is NaN% below the current price of $. This is an average based on projections from 17 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell IQVIA Holdings stock

Buy or sell IQVIA Holdings stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing